Facilitator Guide - EngenderHealth

More documents

Recommendations

Info

Facilitator Guide5. On a chart write the names of all participants vertically in column one. Then makecolumns for the remaining days-days 1, 2, 3, and 4. Every morning when participantsgather they should check the box next to their name if they have taken theirassigned ART. If not they should mark a cross. At the end of the session review theadherence rate.16. Allow for questions to ensure that everyone is clear about their assignment.Adherence to Treatment for HIV36
1SECTION 1Session 1.8 : Resistance to ARTTrainer's notesFACTS ABOUT HIV, AIDS AND ARTFacilitator GuideObjectives1By the end of the session participants will• Understand the meaning of ART resistance.• Understand how resistance occurs and how to prevent it.MethodologyLecture, discussionRecommended TimeAdherence to Treatment for HIV30 minutesMaterials• Flip chart and markers• Participant's manual Session 1.8-Handout A: Questions about resistanceSteps1. One of the main problems we face in ART is that, the drugs may stop working and theHIV virus in that person's body develops what we call resistance to treatment. Howcan we define resistance in a simple way? Facilitate a quick brainstorm, and thenshow this definition on flip chart.Resistance is the ability of HIV virus to multiply (replicate) even when ART is takenregularly. Resistance occurs because of changes in structure of HIV virus.2. Clarify that ART resistance occurs when the HIV in a person's body is no longeraffected by medication, and the HIV is therefore able to multiply and destroyCD4 cells. Explain that ART resistance occurs when people do not take theirmedication regularly.3. To help people understand the concept of resistance, take them through Handouts A.37
Page 1 and 2: Adherence to Treatment for HIVA Tra
Page 3 and 4: © 2006 EngenderHealth Society.F-6/
Page 5 and 6: TABLE OF CONTENTSPREFACEi - iiACKNO
Page 7 and 8: PREFACEWith funding from the Global
Page 9 and 10: ACKNOWLEDGEMENTSWe acknowledge with
Page 11 and 12: ABBREVIATIONSARTCD4GFATMIVDUMSMNNRT
Page 13 and 14: ABOUT THE FACILITATOR GUIDEThe Faci
Page 15 and 16: The steps give detailed, step-by-st
Page 17 and 18: This symbol indicatespoints to be c
Page 19 and 20: ABOUT THE PARTICIPANT MANUALThe Par
Page 22 and 23: SCHEDULE FOR DAY 1Session Title and
Page 24 and 25: Facilitator Guide1Adherence to Trea
Page 26 and 27: 1 SECTION 1Facilitator GuideSession
Page 38 and 39: 1SECTION 1Facilitator GuideSession
Page 40 and 41: Facilitator Guide1As the drugs redu
Page 42 and 43: 1SECTION 1Facilitator GuideFACTS AB
Page 44 and 45: Activity A :Facilitator Guide20 min
Page 48: Facilitator Guide1Adherence to Trea
Page 51 and 52: 2SECTION 2HIV, AIDS AND CHRONIC CAR
Page 53 and 54: 6. Explain thatGood chronic care is
Page 55 and 56: • Rapid treatment scale-up in res
Page 57 and 58: Activity A :15 minutes1. Adherence
Page 59 and 60: 2. Facilitate a brief discussion (1
Page 61 and 62: • Therefore in a client-centered
Page 63 and 64: Case Study #2Satish, a person livin
Page 67 and 68: 2. Give instructions to each group,
Page 71 and 72: one category of clients. Ask some p
Page 75 and 76: 2SECTION 3THE ELEMENTS OF COUNSELIN
Page 77 and 78: Negative nonverbal cues• Reading
Page 83: minutes. The "observer" will facili
Page 89 and 90: 5. Empathy: Ask participants to def
Page 91 and 92: 3. Conclusions: Ask participants: W
Page 95 and 96: 2. Brainstorm "Closed" and "Open-en
Page 97 and 98:
Why should we do this? (Possible an
Page 99 and 100:
3SECTION 3THE ELEMENTS OF COUNSELIN
Page 101 and 102:
3SECTION 3THE ELEMENTS OF COUNSELIN
Page 103 and 104:
Gender and Sexuality1. It is more a
Page 105 and 106:
Sexual Behavior1. It is acceptable
Page 107 and 108:
2. Often counselors have very large
Page 109 and 110:
3SECTION 4SUPPORTING CLIENTS ON ART
Page 111 and 112:
Activity B15 minutes1. Facilitate a
Page 113 and 114:
Page 115 and 116:
8. Clap every 30 seconds, and if yo
Page 117 and 118:
2. Prepare four risk-level cards, u
Page 119 and 120:
Key Messages• Prevention and care
Page 122 and 123:
SCHEDULE FOR DAY 4Session Title and
Page 124 and 125:
Steps1. Explain that in this sessio
Page 126 and 127:
2. Divide the participants into thr
Page 128 and 129:
2. Before the session, you will hav
Page 130 and 131:
It is difficult to assess adherence
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
4SECTION 5EVALUATION AND CLOSURESes
Page 138 and 139:
Closing the Training1. Closing of t
Page 140 and 141:
4SECTION 5EVALUATION AND CLOSURESes
Page 142 and 143:
___________________________________
Page 144 and 145:
16. What drug combination are recom
Page 146 and 147:
136Notes
show all

Facilitator Guide - EngenderHealth

Create successful ePaper yourself

Delete template?

Save as template?